Current Pharmaceutical Design

William A. Banks  
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108


D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy for Anxiety Disorders: An Update

Author(s): Stefan G. Hofmann, Alice T. Sawyer and Anu Asnaani

Affiliation: Department of Psychology, Boston University, 648 Beacon Street, 6th Floor, Boston, MA 02215- 2002,USA


Cognitive behavioral therapy (CBT) has been shown to be an effective intervention for anxiety disorders. However, despite its proven efficacy, some patients fail to respond to an adequate course of treatment. In attempts to improve the efficacy of CBT, researchers have augmented the core learning processes of the intervention with d-cycloserine (DCS), an N-Methyl-D-Aspartate partial agonist. This article reviews the current literature on DCS as an augmentation strategy for CBT for anxiety disorders. We will describe the memory enhancing properties of DCS, review findings from randomized controlled studies of DCS in anxious populations and discuss mechanism, dosing and timing issues.

Keywords: D-cycloserine, anxiety, cognitive behavioral therapy

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [5659 - 5662]
Pages: 4
DOI: 10.2174/138161212803530916
Price: $58